Hidroxicloroquina

Download report

Favorite

Events Timeline

Commercial

Clinical

Drug

Target

Variants

Financial

Trends

Safety

Events Timeline

YTD

Max

Events

FDA approval date

EMA approval date

Patent expiration date

Study first post date

Last update post date

Start date

Primary completion date

Completion date

Results first post date

Mock data
Subscribe for the real data

Commercial

No data

Clinical

Clinical Trials

604 clinical trials

View more details

Mock data
Subscribe for the real data

Indications Phases 4

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Covid-19	D000086382	—	U07.1	13	77	102	25	44	232
Rheumatoid arthritis	D001172	EFO_0000685	M06.9	—	12	19	20	13	61
Coronavirus infections	D018352	EFO_0007224	B34.2	4	19	26	5	12	57
Arthritis	D001168	EFO_0005856	M05-M14	—	13	18	13	12	53
Sars-cov-2	D000086402	—	—	3	17	12	2	3	32
Infections	D007239	EFO_0000544	—	1	10	15	2	6	30
Syndrome	D013577	—	—	3	13	7	2	5	26
Systemic lupus erythematosus	D008180	EFO_0002690	M32	2	4	6	4	11	26
Pneumonia	D011014	EFO_0003106	J18	—	6	7	3	8	23
Communicable diseases	D003141	—	—	1	8	7	1	2	17

Show 63 more

Indications Phases 3

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Coronavirus	D017934	—	—	—	5	8	—	4	17
Severe acute respiratory syndrome	D045169	EFO_0000694	J12.81	2	4	11	—	2	16
Breast neoplasms	D001943	EFO_0003869	C50	7	9	1	—	—	13
Respiratory distress syndrome	D012128	EFO_1000637	J80	1	4	7	—	—	10
Acute lung injury	D055371	EFO_0004610	—	1	4	4	—	—	7
Newborn respiratory distress syndrome	D012127	—	P22	1	4	4	—	—	7
Respiratory tract infections	D012141	—	J06.9	—	—	5	—	—	5
Lupus nephritis	D008181	EFO_0005761	—	—	1	2	—	2	5
Pregnancy rate	D018873	—	—	1	—	1	—	3	5
Respiratory insufficiency	D012131	—	J96.9	—	1	4	—	—	4

Show 34 more

Indications Phases 2

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Neoplasms	D009369	—	C80	14	7	—	—	1	21
Pancreatic neoplasms	D010190	EFO_0003860	C25	8	12	—	—	—	18
Melanoma	D008545	—	—	7	5	—	—	2	11
Lung neoplasms	D008175	—	C34.90	4	9	—	—	—	10
Adenocarcinoma	D000230	—	—	6	7	—	—	1	10
Colorectal neoplasms	D015179	—	—	2	7	—	—	—	9
Prostatic neoplasms	D011471	—	C61	5	6	—	—	—	9
Non-small-cell lung carcinoma	D002289	—	—	4	6	—	—	—	7
Carcinoma	D002277	—	C80.0	5	4	—	—	—	6
Renal cell carcinoma	D002292	EFO_0000376	—	4	2	—	—	—	4

Show 99 more

Indications Phases 1

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Multiple myeloma	D009101	—	C90.0	4	—	—	—	—	4
Plasma cell neoplasms	D054219	—	—	4	—	—	—	—	4
Immunosuppression therapy	D007165	—	—	1	—	—	—	1	2
Digestive system neoplasms	D004067	—	—	2	—	—	—	—	2
Fibrosis	D005355	—	—	2	—	—	—	—	2
Pancreatic ductal carcinoma	D021441	—	—	1	—	—	—	1	2
Erythema	D004890	—	L53.9	1	—	—	—	1	2
Plasmacytoma	D010954	—	C90.3	1	—	—	—	—	1
Myeloid leukemia acute	D015470	—	C92.0	1	—	—	—	—	1
Myeloid leukemia	D007951	—	C92	1	—	—	—	—	1

Show 10 more

Indications Without Phase

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Macular degeneration	D008268	EFO_0001365	H35.30	—	—	—	—	3	3
Retinal diseases	D012164	—	H35.9	—	—	—	—	3	3
Critical illness	D016638	—	—	—	—	—	—	2	2
Diarrhea	D003967	—	R19.7	—	—	—	—	2	2
Psoriatic arthritis	D015535	EFO_0003778	L40.5	—	—	—	—	2	2
Thyroiditis	D013966	—	E06	—	—	—	—	2	2
Hashimoto disease	D050031	EFO_0003779	E06.3	—	—	—	—	2	2
Chronic urticaria	D000080223	—	L50.8	—	—	—	—	2	2
Urticaria	D014581	EFO_0005531	L50	—	—	—	—	2	2
Hair diseases	D006201	—	—	—	—	—	—	2	2

Show 40 more

Epidemiology

Epidemiological information for investigational and approved indications

View more details

Drug

General

Drug common name	—
INN	—
Description	—
Classification	Unknown
Drug class	—
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)	—